Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 29 December 2011 | By Alexander Gaffney, RAC
The US Food and Drug Administration (FDA) announced Wednesday that it is working with healthcare providers, manufacturers, standard-setting organizations and government agencies to "reduce the risk of infection from the inadequate reprocessing of medical devices intended for repeat use."
The FDA noted that it has received reports of patients being exposed to biological products as a result of inadequate sterilization after use. However, FDA also noted that transmission of infection as a result of these biological products-including blood, tissue, and body fluids-was extremely rare.
The deputy director of the Center for Devices and Radiological Health (CDRH), Bill Maisel, M.D., said that the benefits of using such devices far outweigh the low risk of acquiring an infection.
Patients are advised to ask their healthcare providers about precautions taken to promote the sterility of their products. FDA is further working with manufacturers and providers to promote clearer instruction manuals for repeat-use devices and generate best-practices for sterilization.
The FDA is making information available to consumers, providers and manufacturers at a new web page devoted solely to the issue.
Tags: Repeat Use, Sterilization, Latest News, Transmission, safety
Regulatory Focus newsletters
All the biggest regulatory news and happenings.